by Necrotising enterocolitis is a disease that affects the intestine of premature infants. It can cause portions of the intestine to die and can be life-threatening. The disease usually affects extremely premature infants with very low birth weight. Symptoms include abdominal distention, feeding intolerance, and blood in the stool. Treatment involves surgery to remove the damaged portions of the intestine in severe cases. The primary factor leading to the growth of the necrotising enterocolitis market is the rising number of premature births worldwide. Preterm birth rates have increased by 15% globally since 2000. Approximately 1 in 10 babies born prematurely is at risk of developing this disease.
The Necrotising Enterocolitis Market is estimated to be valued at US$ 7.10 Bn in 2024 and is expected to exhibit a CAGR of 5.6% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the necrotising enterocolitis market are AbbVie, AstraZeneca, Baxter International, Bristol-Myers Squibb, and Fresenius Kabi. These players dominate the market with their wide product portfolios and global presence.
Key opportunities:
Increasing investment in research and development of novel therapies, rising awareness about early diagnosis and treatment, and growing neonatal care facilities present significant growth opportunities in the market.
Global expansion:
Key market players are expanding their presence in developing regions of Asia Pacific and Latin America through collaborations and acquisition strategies to tap the high growth potential in these untapped markets.
Market Drivers
Rising premature birth rates worldwide: Preterm birth rates have increased by 15% globally since 2000. This is a major driver behind the growth of the necrotising enterocolitis market as preterm infants are at highest risk of developing this disease.
Improving diagnosis and treatment: Advancements in diagnostic techniques and availability of wide treatment options have improved clinical outcomes and management of necrotising enterocolitis. This increasing efficacy of diagnosis and treatment is expected to boost market growth over the forecast period.
PEST Analysis
Political: Changes in healthcare policies related to newborn care and funding for treatment may impact market growth. For example, favorable reimbursement policies can boost adoption of therapeutics.
Economic: The pricing pressure faced by drugmakers due to economic slowdowns may temporarily impact the revenue stream. However, rising healthcare expenditures overall act as a tailwind over the long-run.
Social: Growing awareness initiatives by non-profits and hospitals help in early detection and management of NEC cases. This raises treatment demand. However, in developing nations, social barriers like low literacy continue to be a challenge.
Technological: Advancements in parenteral nutrition and drug delivery systems aid the clinical management of NEC. Further, technologies that enhance researchers’ understanding of the disease pathways and risk factors can accelerate development of superior interventions.
Geographical Regions Of Concentration
North America currently leads in terms of NEC therapeutics value, given advanced healthcare infrastructure, concentration of key pharma companies and high medical spending. Moreover, Asia Pacific is emerging as a major market owing to rising birthrates, improving access to neonatal care and increasing healthcare expenditures in developing countries.
Fastest Growing Region
Asia Pacific region is expected to witness the fastest growth over the forecast period supported by its huge patient population, growing participation of emerging Asian economies in global healthcare trade and improving research focus of industry players on this region.
What Are The Key Data Covered In This Necrotising Enterocolitis Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Necrotising Enterocolitis Market’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Necrotising Enterocolitis Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Necrotising Enterocolitis Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Necrotising Enterocolitis Market vendors
FAQ’s
Q.1 What are the main factors influencing the Necrotising Enterocolitis Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Necrotising Enterocolitis Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Necrotising Enterocolitis Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author - Ravina Pandya
Ravina Pandya,a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals. LinkedIn Profile
